Skip to Main Content

The University of Tennessee

The College of Veterinary Medicine

Frequently Used Tools:





Daniel A. Ward, DVM, Ph.D.


Professor, Ophthalmology
Department of Small Animal Clinical Sciences
College of Veterinary Medicine
The University of Tennessee
C247 Veterinary Teaching Hospital
Knoxville, TN 37996
Phone: (865) 974-8387
FAX: (865) 974-5554
Email

Education

  • D.V.M., University of Tennessee
  • Ph.D., University of Georgia
  • Post-doc, Clinical Pharmacology, University of Georgia

Research Interests

  • Basic research is in the area of ocular pharmacology, especially as it pertains to control of the blood-ocular barriers and aqueous humor dynamics. Fluorophotometry is our primary research tool for investigating both areas. Clinical research interests are glaucoma, ocular trauma, and equine ophthalmology.

Publications

  • Johnstone NS, Ward DA. The incidence of posterior capsule disruption during phacoemulsification and associated postoperative complication rates in dogs: 244 eyes (1995 –2002), Vet Ophthalmol 8:47-50, 2005.
  • Ward DA, Abney K, Oliver JW. The effects of topical ocular application of 0.25% demecarium bromide on serum acetylcholinesterase levels in normal dogs. Vet Ophthalmol 6:23-25, 2003.
  • Skorobohach BJ, Ward DA, Hendrix DVH. Effects of orally administered methazolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs. Am J Vet Res64:183-187, 2003.
  • Ward DA, Cawrse MA, Hendrix DVH. Fluorophotometric determination of aqueous humor flow rate in clinically normal dogs.Am J Vet Res 62:853-858, 2001.
  • Cawrse MA, Ward DA, Hendrix DVH. Effects of topical application of a % solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs. Am J Vet Res 62:859-863, 2001.
  • Ward DA, Barnhill MA. Extracellular matrix promotes differentiation of retinal pigment epithelium. In VitroCell Dev Biol, 33:588-591, 1997.
  • Ward DA. Comparative efficacy of topically applied flurbiprofen, diclofenac, tolmetin, and suprofen for the treatment of experimentally induced blood-aqueous barrier disruption in dogs. Am J Vet Res 57:875-878, 1996.
  • Martin CL, Kaswan R, Gratzek A, Champagne E, Salisbury MA,Ward DA. Ocular use of tissue plasminogen activator in companion animals. Prog Vet Compar Ophthalmol 3:29-36,1993.
  • Ward DA, Ferguson DC, Ward SL, Green K, Kaswan RL. Comparison of the blood-aqueous barrier stabilizing effects of steroidal and nonsteroidal antiinflammatory agents in the Dog. Prog Vet Comp Ophthalmol 2:117-124,1992.
  • Ward DA, Ferguson DC, Kaswan RL, Green K. Leukotrienes and sensory innervation in blood-aqueous barrier disruption in the dog. J Ocular Pharm 8:69-76,1992.
  • Ward DA, Clark ES. Ocular Pharmacology. Veterinary Clinics of North America: Food Animal Practice 7:779-791, 1991.
  • Ward DA, Ferguson DC, Kaswan RL, Green K, Bellhorn RW. Fluorophotometric evaluation of experimental blood-aqueous barrier breakdown in dogs. Am J Vet Res52: 1433-1437, 1991.

  • Ward DA. Ocular pharmacology. In Bonagura JD, Kirk RW (eds): Kirk’s Current Veterinary Therapy XIV. St. Louis: Elsevier Inc., 2007.
  • Ward DA. Local anesthesia of the eye. In Doherty T, Valverde A (eds): Manual of equine anesthesia and analgesia. Oxford: Blackwell Publishing, 2006, pp.286-292.
  • Ward DA. Ocular Pharmacology Part 3. Mydriatics/cycloplegics, anesthetics, tear substitutes and stimulators, intraocular irrigating fluids, disinfectants, viscoelastics, fibrinolytics and antifibrinolytics, antifibrotic agents, tissue adhesives, and anticollagenase agents. In Gelatt KN (ed): Veterinary Ophthalmology. Philadelphia: Lippincott Williams & Wilkins, 1999, pp. 336-354.